Inventor · disambiguated record
Scott W. Martin
Also filed as: MARTIN SCOTT W
23 granted patents·1 pending application·448 citations·filing 1992–2021
96Inventor score
Top patents by PatentIndex Score
24 records- 0198US7153848B2Inhibitors of HCV replicationBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 26, 2006·90 cites·32 claims
- 0297US7348425B2Inhibitors of HCV replicationBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Mar 25, 2008·59 cites·1 claims
- 0395US9850225B2Compounds useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 26, 2017·13 cites·15 claims
- 0492US7473688B2Indolobenzazepine HCV NS5B inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 6, 2009·26 cites·15 claims
- 0591US7521441B2Cyclopropyl fused indolobenzazepine HCV NS5B inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Apr 21, 2009·18 cites·12 claims
- 0691US6271249B1Diphenyl imidazoles as potassium channel modulatorsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Aug 7, 2001·38 cites·8 claims
- 0790US7456165B2HCV NS5B inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Nov 25, 2008·17 cites·8 claims
- 0889US7183302B2Iminothiazolidinones as inhibitors of HCV replicationBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 27, 2007·32 cites·19 claims
- 0988US10669272B2Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 2, 2020·4 cites·13 claims
- 1088US5869509ADiphenyl oxadiazolones as potassium channel modulatorsBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Feb 9, 1999·63 cites·14 claims
- 1185US11866430B2Naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 9, 2024·3 cites·11 claims
- 1281US7112601B2Cycloalkyl heterocycles for treating hepatitis C virusBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Sep 26, 2006·15 cites·11 claims
- 1381US5254576ADiphenyl-heterocyclic-oxazole as platelet aggregation inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1992·Granted Oct 19, 1993·18 cites·21 claims
- 1480US7652004B2Compounds for the treatment of hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jan 26, 2010·4 cites·17 claims
- 1578US8133884B2Compounds for the treatment of hepatitis CMARTIN SCOTT W·Filed 2009·Granted Mar 13, 2012·5 cites·13 claims
- 1676US6077861ADiphenyl triazoles as potassium channel modulatorsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Jun 20, 2000·30 cites·12 claims
- 1772US5380854ADiphenyl-heterocyclic-oxazole as platelet aggregation inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Jan 10, 1995·10 cites·3 claims
- 1871US7642251B2Compounds for the treatment of hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jan 5, 2010·1 cites·16 claims
- 1967US11713316B2Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Aug 1, 2023·0 cites·11 claims
- 2063US6479482B2Alkylamine derivatives of dihydropyridine NPY antagonistsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 12, 2002·2 cites·9 claims
- 2161US10954238B1Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Mar 23, 2021·0 cites·11 claims
- 2254US11964973B2Substituted bicyclic compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 23, 2024·0 cites·11 claims
- 2351US8143243B2Compounds for the treatment of hepatitis CMARTIN SCOTT W·Filed 2009·Granted Mar 27, 2012·0 cites·3 claims
- 2451US2023089255A1Combinations of dgk inhibitors and checkpoint antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott W. Martin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →